Elias Karl M.
- Country
- Germany
- Department
- Universitatsklinikum Heidelberg( #1)
Research Overview
Data & Insights
Has run more than one trial at 2 of 46 partner sites.
Specializations
Hematologic Oncology
The investigator specializes in researching innovative therapeutic approaches for multiple myeloma, with particular focus on treatment strategies for patients with relapsed and refractory disease.
- Multiple Myeloma Treatment
- Blood Cancer Therapies
- Hematologic Malignancies
The investigator explores combination therapy approaches in hematologic oncology, specifically targeting chromosomal alterations in multiple myeloma patients.
Targeted Therapies
Clinical research activities focus on the development and implementation of targeted therapeutic combinations for blood cancers, particularly investigating novel drug combinations for specific genetic profiles.
- Antibody-Drug Conjugates
- BCL-2 Inhibition
- Precision Medicine
The investigator examines personalized treatment approaches based on specific genetic markers in hematologic malignancies.
Treatment Resistance
Research interests include addressing treatment resistance in multiple myeloma, focusing on novel therapeutic strategies for patients who have failed previous lines of therapy.
- Refractory Disease Management
- Drug Resistance Mechanisms
- Novel Treatment Approaches
The investigator studies innovative treatment solutions for patients with limited therapeutic options.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.